Kiniksa Pharmaceuticals International (KNSA) Inventory (2021 - 2026)

Kiniksa Pharmaceuticals International's Inventory history runs 6 years deep, the most recent figure standing at $73.1 million for Q1 2026.

• Quarterly Inventory rose 231.42% year-over-year to $73.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.1 million (up 231.42% YoY) and the FY2025 annual result came in at $54.9 million, up 108.22% from the prior year.
• Inventory was $73.1 million for Q1 2026 at Kiniksa Pharmaceuticals International, up from $54.9 million in the prior quarter.
• Across five years, Inventory topped out at $73.1 million in Q1 2026 and bottomed at $13.2 million in Q1 2022.
• A 5-year average of $31.2 million and a median of $26.4 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory soared 504.07% — and 2025, when it fell 19.1%.
• Kiniksa Pharmaceuticals International's Inventory stood at $21.6 million in 2022, then surged by 44.09% to $31.1 million in 2023, then decreased by 15.29% to $26.4 million in 2024, then surged by 108.22% to $54.9 million in 2025, then jumped by 33.24% to $73.1 million in 2026.
• Business Quant data shows KNSA's Inventory at $73.1 million in Q1 2026, $54.9 million in Q4 2025, and $41.4 million in Q3 2025.